Evidence map›Paper›PMID 28154970›Full record

ArticleJournal of neurology2017

Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey.

Luca Bartolini, Eyal Muscal

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 48 citations in OpenAlex.

  1. Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2019
    Trial
  2. Article
  3. Immunotherapy for autoimmune encephalitis.Cell death discovery · 2025
    Review
  4. Review
  5. Recent research on immunotherapy for anti-N-methyl-D-aspartate receptor encephalitis.Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Review
  6. Do the neurologists recognize autoimmune epilepsy well enough? What is the effect of the pandemic on this matter?Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The Chinese experience with anti-NMDAR encephalitis.Annals of translational medicine · 2020
    Article
  15. Article
  16. Anti-NMDAR encephalitis: A single-center, longitudinal study in China.Neurology(R) neuroimmunology & neuroinflammation · 2020
    Article
  17. Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.Annals of clinical and translational neurology · 2018
    Article
  18. An Update on the Treatment of Pediatric Autoimmune Encephalitis.Current treatment options in rheumatology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Luca BartoliniCenter for Neuroscience, George Washington University, Children's National Health System, 111 Michigan Ave NW, Washington, DC, 20010, USA. LBartoli@childrensnational.org.ORCID http://orcid.org/0000-0003-2755-8218
Eyal MuscalDepartment of Pediatrics, Sections of Immunology, Allergy and Rheumatology and Co-appointment in Child Neurology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Baylor College of Medicine · USChildren's National · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of the study was to identify differences in treatment strategies for anti-NMDA receptor encephalitis based on specialty of treating physicians, geographic location, and years in practice. We conducted an anonymous worldwide electronic survey through the Practice Current section of Neurology

Indexed as

Anti-N-Methyl-D-Aspartate Receptor EncephalitisChi-Square DistributionEuropeFemaleGlobal HealthHealth SurveysHumansImmunoglobulins, IntravenousImmunotherapyMaleNeurologistsPlasma ExchangeUnited StatesImmunoglobulins, IntravenousAnti-NMDA receptor encephalitisImmunotherapyTreatment

Identifiers

PMID28154970
OpenAlexW2583829171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.